EMEA News Q3 2025

Switzerland Advances National Strategy
on ME/CFS and Long Covid

Switzerland Moves Towards National Strategy on ME/CFS and Long Covid

On 14 August, the Swiss Council of States’ Commission for Social Security and Health (SGK-S) unanimously recommended the adoption of a National Strategy for ME/CFS and Long Covid, a significant step forward for patients affected by these debilitating conditions, as well as by Post-Vac Syndrome (PVS).

The motion, tabled by MP Lorenz Hess, has already been approved by both the Federal Council and the National Council. With the backing of SGK-S, it is now expected to pass the final hurdle when the Council of States votes during its autumn session in mid-September.

The initiative has been strongly supported by patient organisations, including EMEA Switzerland ME/CFS Switzerland (ME/CFS Switzerland), who have collaborated to bring the issue into parliamentary debate.

The urgent need was stressed the for the following:

  • Increased research funding,
  • Specialist competence and treatment centres,
  • Access to home-based care, and
  • Greater awareness and education for healthcare professionals and the public.

Campaigners have welcomed the cross-party consensus, describing this development as a milestone in securing better and more humane care for people living with ME/CFS and Long Covid in Switzerland.

The discussion echoes international calls for greater recognition and resources: the World Health Organization classifies myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) as a neurological disease, affecting both quality of life and long-term health outcomes. Long Covid has further highlighted systemic gaps in research and care, bringing renewed urgency to the need for coordinated national strategies across Europe.

The vote expected in mid-September will mark a decisive moment: if passed, Switzerland would put in place one of Europe’s first national strategies specifically dedicated to improving care and research for ME/CFS and Long Covid.

Further Information:


Last Update: August 2025